Pancreatic neuroendocrine tumors: pathologic and molecular characteristics
C Shi, DS Klimstra - Seminars in Diagnostic Pathology, 2014 - Elsevier
Pancreatic neuroendocrine neoplasms include mainly well-differentiated neuroendocrine
tumors but also rare poorly differentiated neuroendocrine carcinomas. Molecular …
tumors but also rare poorly differentiated neuroendocrine carcinomas. Molecular …
[HTML][HTML] Pancreatic neuroendocrine tumors: molecular mechanisms and therapeutic targets
Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …
whose causation is only partly understood. An increasing number of studies have uncovered …
Pancreatic neuroendocrine neoplasms: landscape and horizon
LH Tang - Archives of Pathology & Laboratory Medicine, 2020 - meridian.allenpress.com
Context.—Since the initial description of pancreatic endocrine physiology and the
recognition of islet cell tumors in the 1800s, there have been noteworthy advances in the …
recognition of islet cell tumors in the 1800s, there have been noteworthy advances in the …
[HTML][HTML] Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
C Ro, W Chai, EY Victoria, R Yu - Chinese journal of cancer, 2013 - ncbi.nlm.nih.gov
Pancreatic neuroendocrine tumors (PNETs), a group of endocrine tumors arising in the
pancreas, are among the most common neuroendocrine tumors. The genetic causes of …
pancreas, are among the most common neuroendocrine tumors. The genetic causes of …
Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3
B Konukiewitz, M Jesinghaus, K Steiger, AM Schlitter… - Human pathology, 2018 - Elsevier
Pancreatic neuroendocrine carcinoma is a rare aggressive tumor commonly harboring TP53
and RB1 alterations and lacking neuroendocrine-related genetic changes such as mutations …
and RB1 alterations and lacking neuroendocrine-related genetic changes such as mutations …
Pancreatic neuroendocrine tumors
SN Salaria, C Shi - Surgical pathology clinics, 2016 - Elsevier
Pancreatic neuroendocrine neoplasms include well-differentiated pancreatic
neuroendocrine tumors (PanNETs) and neuroendocrine carcinomas (NECs) with well …
neuroendocrine tumors (PanNETs) and neuroendocrine carcinomas (NECs) with well …
Pancreatic neuroendocrine tumors: a comprehensive review
C Zhou, J Zhang, Y Zheng, Z Zhu - International journal of …, 2012 - Wiley Online Library
Pancreatic neuroendocrine tumors (NETs) are a heterogeneous group of tumors. Despite
being relatively rare, representing just 1–2% of all pancreatic neoplasms, the incidence of …
being relatively rare, representing just 1–2% of all pancreatic neoplasms, the incidence of …
Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies
J Arakelyan, D Zohrabyan, PA Philip - Cancer, 2021 - Wiley Online Library
Pancreatic neuroendocrine neoplasms (panNENs) are the second most common epithelial
tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it …
tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it …
[HTML][HTML] Molecular pathology of pancreatic neuroendocrine tumors
M Chen, M Van Ness, Y Guo… - Journal of gastrointestinal …, 2012 - ncbi.nlm.nih.gov
Pancreatic endocrine tumors (PETs) are rare neoplasms which account for 1% to 2% of all
pancreatic malignancies. The diagnostic, grading and prognostic criteria for PETs have …
pancreatic malignancies. The diagnostic, grading and prognostic criteria for PETs have …
Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information
MR Wick, FM Graeme-Cook - Pathology Patterns Reviews, 2001 - academic.oup.com
Pancreatic endocrine tumors (PETs) continue to be challenging diagnostic and prognostic
lesions in surgical pathology and clinical medicine. These neoplasms can be graded into 1 …
lesions in surgical pathology and clinical medicine. These neoplasms can be graded into 1 …